NASDAQ:BRKR - Bruker Stock Price, News, & Analysis

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker declared a quarterly dividend on Friday, February 15th. Investors of record on Tuesday, March 5th will be paid a dividend of $0.04 per share on Friday, March 22nd. This represents a $0.16 dividend on an annualized basis and a yield of 0.41%. The ex-dividend date of this dividend is Monday, March 4th. View Bruker's Dividend History.

Bruker announced that its board has authorized a share repurchase program on Sunday, June 4th 2017, which authorizes the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings data on Monday, February, 11th. The medical research company reported $0.54 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.54. The medical research company earned $553.60 million during the quarter, compared to analysts' expectations of $544.53 million. Bruker had a net margin of 9.48% and a return on equity of 26.36%. View Bruker's Earnings History.

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Bruker.

Bruker updated its FY 2019 earnings guidance on Monday, February, 11th. The company provided earnings per share guidance of $1.54-1.58 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.55. The company issued revenue guidance of $2.009-2.028 billion, compared to the consensus revenue estimate of $1.97 billion.

5 Wall Street analysts have issued 12-month price targets for Bruker's shares. Their predictions range from $30.00 to $44.00. On average, they anticipate Bruker's share price to reach $35.80 in the next year. This suggests that the stock has a possible downside of 8.8%. View Analyst Price Targets for Bruker.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 1 hold rating, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker.

Media headlines about BRKR stock have been trending somewhat positive this week, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Bruker earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave news coverage about the medical research company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Some companies that are related to Bruker include Advanced Micro Devices (AMD), Constellation Software (CSU), Relx (RELX), TOKYO ELECTRON/ADR (TOELY), Motorola Solutions (MSI), SMC CORP JAPAN/S (SMCAY), Palo Alto Networks (PANW), Arista Networks (ANET), CGI (GIB.A), Shopify (SHOP), Hewlett Packard Enterprise (HPE), Verisign (VRSN), Kyocera (KYOCY), Check Point Software Technologies (CHKP) and Microchip Technology (MCHP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include General Electric (GE), Mattel (MAT), Ultra Clean (UCTT), Twitter (TWTR), Clear Channel Outdoor (CCO), American National BankShares (AMNB), US Foods (USFD), Buffalo Wild Wings (BWLD), New York Times (NYT) and Enterprise Bancorp (EBTC).

Bruker's stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (4.24%), BlackRock Inc. (3.49%), Acadian Asset Management LLC (2.55%), D. E. Shaw & Co. Inc. (1.36%), Norges Bank (1.06%) and Bank of America Corp DE (0.86%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker.

BRKR stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Acadian Asset Management LLC, BTIM Corp., Prudential Financial Inc., QS Investors LLC, Citigroup Inc., D. E. Shaw & Co. Inc. and Bank of Montreal Can. View Insider Buying and Selling for Bruker.

BRKR stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, First Trust Advisors LP, Thrivent Financial for Lutherans, Bank of America Corp DE, Mackay Shields LLC, Segantii Capital Management Ltd, Millennium Management LLC and Canada Pension Plan Investment Board. View Insider Buying and Selling for Bruker.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BRKR stock can currently be purchased for approximately $39.26.

Bruker has a market capitalization of $6.15 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

The official website for Bruker is http://www.bruker.com.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]